Clinical Trials Browser

Phase 2 × Hypersensitivity × Endocrine × Clear all

NCT01673906 2025-06-24

68-Ga-labeled Octreotide Analogues PET in Duodenal-pancreatic Neuroendocrine Tumours

Phase 2 Completed

Hypersensitivity, Neuroendocrine Tumors